Given that this study is a preliminary to future RCTs, our findings suggest that a ω-3 supplement, in the context of a Mediterranean diet and vitamin D administration, gives benefits to children with T1D, with a reduction of insulin requirements after 12 months of supplementation, despite a decrease in FCP. Here, INS is linked to type 1 diabetes mellitus.